Navigation Links
Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Date:2/5/2008

ALLEGAN, Mich., Feb. 5 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO; TASE) announced today that Joseph Papa, Perrigo's Chairman and CEO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, at 11:40 a.m. (ET) at the Grand Hyatt Hotel in New York.

Perrigo Company is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients (API) and consumer products. The Company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market. The Company's primary markets and locations of manufacturing facilities are the United States, Israel, Mexico and the United Kingdom. Visit Perrigo on the Internet (http://www.perrigo.com).


'/>"/>
SOURCE Perrigo Company
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Perrigo Announces Final FDA Approval of Dexcels OTC Omeprazole; Raises Full Year Earnings Guidance
2. Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
3. Brazilian National Biosafety Technical Committee Approves Monsanto Company Insect-Protected Corn Trait
4. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
5. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
6. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
7. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
8. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
9. NASA technology forms the basis for a new nanotechnology company
10. Solazyme, Inc. Selected by AlwaysOn as a GoingGreen 100 Top Private Company Award Winner
11. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...5/PRNewswire/--BiotechfirmReplikinsLtd.,whichhasan...hroughtheprediction,outbreak,andprogressofthecurre...ysisofthevirus.Thenewdatashowsthatthelethalityofth....d.4.5)duringthevirus,scurrentoutbreakinthespringo...0.1).TheH1N1virus,infectivitycount,however,remains...
(Date:11/25/2009)...ov.25/PRNewswire/-Cytochromatodayannouncedtheappoi...dtwillreplaceMr.UlrikSporkastheNovoA/Srepresentati...nsunchangedatsixmembers. ,, "Weareverypleasedto...ingfromhisexperienceandguidanceasCytochromacontinu...altypharmaceuticalcompany,"statedAlanLewis,PhD,Cha...
(Date:11/25/2009)....25/PRNewswire-FirstCall/--ArdeaBiosciences,Inc.(N...D.,presidentandchiefexecutiveofficer,willpresentat...,Presentationdetailsareasfollows:,PiperJaffray21s...,2009,Time:2:00p.m.EasternTime,Location:TheNewYork...corporate-ir.net/ireye/,target=,_blank,title=,htt...
(Date:11/24/2009)... Ambassador to also Visit Detroit , ...Who: David Appia, French Ambassador for Internatio... in France Agency, , , , ,What: Ambassador Appia ...pro-business initiatives adopted by France to furt...dscape for innovation and development., , ,When: A...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...Wis. -- Metavante Corp., the financial technology...orp, has completed its acquisition of Birmingham,...e a Metavante subsidiary and continue to operate u...re banking processing and customer service to comm... from Kirchman Corp., a Metavante company. Brasfie...
...dge releasing vitamins and minerals. Image courte...being marketed as an aid to holding off the cold a...aukee company. , ,New York-based Brain Twist Inc....t -- a vitamin and mineral enhanced immune boostin...egussa FreshTech Beverages in Milwaukee. , ,Fresh...
...ted that the typical customer is bombarded with mo... surprising that consumers are ignoring all but th...dvertising and mass media as one-in-the-same. A go...d across mass media as often as possible. A succes... several times. , ,Jay Townley, president of Bike...
Other Biology Technology:Turning ads into sales: Context is king 2Turning ads into sales: Context is king 3Turning ads into sales: Context is king 4
(Date:11/24/2009)... For thousands of years it has been prescribed by ...ailments from headaches and stomach pain to fever ... Newcastle University have been able to scientific...s crenata otherwise known as Brazilian mint. , ...the team led by researcher Graciela Rocha was able...
(Date:11/24/2009)... Stents that keep weakened and flabby arteries fro... six months, those stents are no longer needed -- ...necessary. Previously, doctors had no choice but t...of Tel Aviv University,s Department of Biomedical ...er platform that carries drugs where they,re neede...
(Date:11/24/2009)..., BATON ROUGE Antarctica has long held secrets o...d until recently, there has been very little infor...eneath miles of ice for millions of years. Now, a ...ing LSU have been funded to the tune of $10 milli...NSF, to get to the bottom of things literally. Th...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 1Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 2Texcel Medical Expands Medical Device Development 26 Manufacturing Capabilities With New Personnel Nearly 241 Million in Capital Investments 13501 3TeamStaff Inc To Announce Third Quarter Results 54190 1TeamStaff Inc To Announce Third Quarter Results 54190 2TeamStaff Inc To Announce Third Quarter Results 54190 3Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets 54186 1Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets 54186 2
... , BETHESDA, Md. (Jan. 6, 2009) − Obstructi...elevates blood pressure within the brain and event...changes and prevent damage to itself, according to...al Society. The findings may help explain why peop...kes and to die in their sleep. , Sleep apnea is t...
... January 6, 2009, St. Louis, MO As adolescents m...ts due to school or work can begin to impact eatin...n the January 2009 issue of the Journal of the Am... that while young adults enjoy and value time spen...les reported lacking time to sit down and eat a me...
... COLD SPRING HARBOR, N.Y. (Mon., Jan. 5, 2009) ...ols ( www.cshprotocols.org/TOCs/toc1_09.dtl ) fea...for the analysis of molecular processes involved i...f proteins. , Homologous recombination is an impo...mes. When this occurs, a Displacement Loop, or "D...
Other Biology News:Study helps explain connection between sleep apnea, stroke and death 2Study helps explain connection between sleep apnea, stroke and death 3Young adults need to make more time for healthy meals 2Methods for studying DNA repair and protein modification are featured in CSH Protocols 2
BAC Sequencing from Bio S&T
Mouse Anti-LAT Monoclonal Antibody, Unconjugated, Clone LAT1111 from BioLegend
Armenian Hamster Anti-ICOS LEAF™ Monoclonal Antibody, Unconjugated, Clone C398.4A from BioLegend
Starter Accessory Package I from Bethyl Laboratories
Biology Products: